Search Results - "Hellström, P.M."
-
1
-
2
Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man
Published in Regulatory peptides (27-11-2009)“…Peptide tyrosine-tyrosine (PYY) is a prandially controlled hormone in endocrine ileal and colonic mucosa cells. In plasma, PYY appears as full-length PYY1-36…”
Get full text
Journal Article -
3
Greatly increased luminal nitric oxide in ulcerative colitis
Published in The Lancet (British edition) (17-12-1994)“…A role for nitric oxide (NO) in ulcerative colitis has been suggested because mucosal NO synthase activity, measured by indirect assays, is increased in this…”
Get more information
Journal Article -
4
-
5
Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat
Published in Regulatory peptides (15-07-2004)“…Orexin A (OXA) is found in the central nervous system (CNS) and in the gut. Peripheral administration of OXA to rats results in an inhibition of fasting…”
Get full text
Journal Article -
6
-
7
P286 LOW ENERGY DIET CAUSES SIGNIFICANT LOSS IN LEAN BODY MASS
Published in Clinical nutrition. Supplements (2009)Get full text
Journal Article -
8
The pancreatic polypeptide family and the migrating motor complex of the rat: Differential effects in the duodenum and jejunum
Published in Regulatory peptides (01-03-2007)“…To investigate the effects of members of the pancreatic polypeptide family on migrating myoelectric complexes in rats in vivo. Rats were supplied with bipolar…”
Get full text
Journal Article -
9
Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability
Published in European journal of pharmaceutics and biopharmaceutics (01-06-2021)“…[Display omitted] Accurate in vivo predictions of intestinal absorption of low solubility drugs require knowing their solubility in physiologically relevant…”
Get full text
Journal Article -
10
Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS
Published in Baillière's best practice & research. Clinical gastroenterology (01-06-2019)“…By administering an anaerobic cultivated human intestinal microbiota (ACHIM) via upper gastrointestinal route using endoscopy we aimed to rectify intestinal…”
Get full text
Journal Article -
11
-
12
-
13
-
14
-
15
Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients
Published in Regulatory peptides (2013)“…In animal and human studies glucagon-like peptide-2 (GLP-2) has been shown to increase blood flow in the superior mesenteric artery and the portal vein. This…”
Get full text
Journal Article -
16
P038 Neuropeptide S: effects on motility, contractility and inflammation in the rat and human gastrointestinal tract
Published in Journal of Crohn's and colitis (01-02-2014)Get full text
Journal Article -
17
Receptor-mediated inhibition of small bowel migrating complex by GLP-1 analog ROSE-010 delivered via pulmonary and systemic routes in the conscious rat
Published in Regulatory peptides (10-11-2012)“…ROSE-010, a Glucagon-Like Peptide-1 (GLP-1) analog, reduces gastrointestinal motility and relieves acute pain in patients with irritable bowel syndrome (IBS)…”
Get full text
Journal Article -
18
Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats
Published in Regulatory peptides (2009)“…The impact of exposure of the intestinal mucosa to acid and hyperosmolal solutions on the release of the inhibitory gut peptides somatostatin (SOM),…”
Get full text
Journal Article -
19
-
20
Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety
Published in Regulatory peptides (15-11-2003)“…Glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) are secreted in parallel to the circulation after a meal. Intravenous (IV) GLP-1 has an…”
Get full text
Journal Article